Uncategorized

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: you can find all the latest Ipsen Group press releases here.

January 15, 2018

Ipsen and Exelixis to host joint investor briefing on Phase 3 CELESTIAL trial results presented at ASCO GI

News | Uncategorized News Article

January 4, 2018

Ipsen to present at the J.P. Morgan Healthcare Conference – January 10, 2018, at 10:00 am PST

News | Uncategorized News Article

December 29, 2017

Ipsen wishes you the best for 2018

News | Uncategorized News Article

December 20, 2017

Ipsen’s partner Exelixis announces U.S. FDA approval of CABOMETYX® Tablets for previously untreated advanced renal cell carcinoma

News | Uncategorized News Article

December 19, 2017

Ipsen delivers strong sales growth of 22.6% for the third quarter of 2017

News | Uncategorized News Article

December 19, 2017

Ipsen announces its corporate agenda for 2018

News | Uncategorized News Article

December 18, 2017

Dr James A. Levine appointed President of the Fondation IPSEN

News | Uncategorized News Article

December 4, 2017

Ipsen to Present at the Citi 2017 Global Healthcare Conference

News | Uncategorized News Article

November 30, 2017

Ipsen supports Movember to change the face of men’s health

News | Uncategorized News Article

November 10, 2017

Ipsen supports awareness of Neuroendocrine Tumors (NET) and the NET Cancer Day on November 10, 2017

News | Uncategorized News Article

<
1
2
3
4
>

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023